Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose atorvastatin before primary PCI in STEMI
ACTRN12615000019505Phase 4Completed
- Sponsor
- Suci Indriani
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute ST-segment elevation myocardial infarction (STEMI) comparing Atorvastatin before primary PCI with Placebo before primary PCI (2 arms). Primary endpoint: Index of microcirculatory resistance. Started Jan 2014; status: completed.
02
Drugs
atorvastatin
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ACTRN12615000019505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000019505.